Intuitive Surgical/$ISRG
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Intuitive Surgical
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
- Ticker
- $ISRG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 17,021
- Headquarters
- Sunnyvale, United States
- Website
- www.intuitive.com
ISRG Metrics
BasicAdvanced
$167B
58.27
$8.27
1.46
-
Price and volume
Market cap
$167B
Beta
1.46
52-week high
$603.88
52-week low
$328.57
Average daily volume
2.4M
Financial strength
Current ratio
4.157
Quick ratio
2.316
Profitability
EBITDA (TTM)
4,528.8
Gross margin (TTM)
66.64%
Net profit margin (TTM)
25.54%
Operating margin (TTM)
31.70%
Effective tax rate (TTM)
17.85%
Revenue per employee (TTM)
$680,000
Management effectiveness
Return on assets (TTM)
11.88%
Return on equity (TTM)
17.93%
Valuation
Price to earnings (TTM)
58.27
Price to revenue (TTM)
14.708
Price to book
10.44
Price to tangible book (TTM)
10.97
Price to free cash flow (TTM)
47.329
Free cash flow yield (TTM)
2.11%
Free cash flow per share (TTM)
10.186
Growth
Revenue change (TTM)
20.45%
Earnings per share change (TTM)
9.47%
3-year revenue growth (CAGR)
19.11%
10-year revenue growth (CAGR)
16.02%
3-year earnings per share growth (CAGR)
24.86%
10-year earnings per share growth (CAGR)
14.92%
What the Analysts think about ISRG
Analyst ratings (Buy, Hold, Sell) for Intuitive Surgical stock.
Analyst projections of the future price of Intuitive Surgical stock.
Bulls say / Bears say
Worldwide procedures rose 16% in Q2, while revenue increased 19% to $2.89 billion. This shows strong demand is still translating into sales growth. (GlobeNewswire)
Da Vinci placements rose to 468 in Q2 from 395 a year earlier, including 246 da Vinci 5 systems versus 180. That uptake supports a multi-year upgrade cycle and continued growth in the installed base. (GlobeNewswire)
Ion procedures grew 36% in Q2 and its installed base expanded 21% year on year. That suggests Intuitive’s growth is extending beyond its core da Vinci platform. (GlobeNewswire)
Da Vinci procedure growth slowed to 15% globally in Q2, while US growth eased to 12% from 14% in Q1. Management expects full-year growth of 13.5%–15.5%, closer to the midpoint, leaving less room for disappointment at a premium-priced stock. (TradingView News, GlobeNewswire)
The planned extended-use programme will let some instruments be used more times, lowering customers’ cost per procedure from 2027. Intuitive has not yet quantified the effect, so higher procedure volumes may not fully offset lower instrument revenue per operation. (Trefis)
The 2026 gross-margin outlook still assumes tariffs will cost about 1% of revenue, while Q2 margins benefited from a refund of previously paid tariffs. That leaves profitability exposed to trade costs and makes part of the recent margin strength less repeatable. (GlobeNewswire, TradingView News)
Data summarised monthly by Lightyear AI. Last updated on 14 Oct 2026.
ISRG Financial Performance
Revenues and expenses
ISRG Earnings Performance
Company profitability
Upcoming events
No upcoming events
ISRG News
AllArticlesVideos
Funds containing ISRG
AllUSDEURGBP
Fund name | Fund size | $ISRG weighting |
|---|---|---|
iShares Automation & Robotics£RBTX | $4.9B | 2.99% |
iShares Automation & Robotics$RBOT | $4.9B | 2.99% |
iShares Automation & Robotics€2B76 | $5.3B | 2.99% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 2.33% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 2.30% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.